Snowball logo
logo
IMMN

Immunovia publ AB

IMMNOV β€’ ST
SEK 0.164+SEK 0.0018Β  (1.11%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
0.8441.1451.5750.9310.6850.919
COGS
(14.97)4.2116.682107.980.1936.93
Gross Profit
15.81(3.066)(5.107)0.931(79.5)(15.9)
Operating Expenses & Income
Operating Income
(166.7)(191.2)(296.5)(109.4)(79.5)(79.82)
Total Operating Expenses
182.6188.1291.4110.38180.55
R&D Expenses
4347.934.4228.45-16.82
Selling General & Admin Expenses
82.6185.2279.5829.0534.225.03
Earnings from Continuing Operations
Interest Expense
(1.432)(1.6)(1.166)(1.86)(66.07)(27.16)
Interest Income
10.6623.0622.8434.730.545.197
Income Tax Expense
1.432(23.06)309.4---
Net Income
Net Income
(157.4)(145)(309.4)(76.54)(145.9)(106.6)
Supplemental
EBIT
(154.5)(166.5)(308.3)(74.68)(79.5)(79.03)
EBITDA
(135.5)(141.6)(166.6)(61.27)(77.18)(77.57)
In millions of SEK, except % and values per 1 share